Table. 2.

Comparison of pain intensity and opioid consumption between non-responder and responder groups after neurolytic celiac plexus block

Variable Non-responder (n = 255) Responder (n = 258) P value
Basal NRS 6.0 (4.0-7.0) 6.0 (4.0-8.0) 0.094
Post NCPB NRS 5.0 (3.0-6.0) 2.0 (1.0-3.0) < 0.001
Basal MED 226.0 (75.0-381.0) 224.0 (73.5-397.5) 0.850
Post NCPB MED 156.0 (75.0-369.0) 180.0 (102.3-417.3) 0.475
Number of patients with opioid reduction 89 (34.9) 134 (51.9) < 0.001

Values are presented as medians (interquartile range) or numbers (%).

An NRS was used to assess the pain intensity. All opioid consumption was standardized to oral MED.

NRS: numerical rating scale, NCPB: neurolytic celiac plexus block, MED: morphine equivalent dose.

Korean J Pain 2021;34:479~486 https://doi.org/10.3344/kjp.2021.34.4.479
© Korean J Pain